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Background
Late gadolinium enhancement (LGE) by cardiac magnetic
resonance (CMR) is a common finding in patients with
hypertrophic cardiomyopathy (HCM), and its extent cor-
relates with clinical parameters such as ventricular tachy-
cardia and sudden cardiac death. While LGE has been
shown to reflect focal replacement fibrosis, recently opti-
mized T1 mapping techniques have allowed for the quan-
tification of extracellular volume (ECV), a measure of the
diffuse interstitial fibrosis also observed in HCM. How-
ever, the relationship between LGE and ECV in HCM is
not fully understood. The aim of this study was to evaluate
the relationship between LGE and ECV in patients with
HCM.
Methods
A retrospective chart review identified patients with a
diagnosis of HCM referred for CMR at Northwestern
Memorial Hospital between 1/1/2012 and 12/31/2014.
Conventional segmented, inversion-recovery gradient
recalled echo imaging was used to generate a stack of
short axis images for LGE quantification using automated
software (Medis). T1 mapping utilized pre- and 12-25
minutes post-contrast balanced steady state free preces-
sion (bSSFP) single-shot Modified Look-Locker inversion-
recovery with data acquisition over 11 heartbeats. Three
short axis slices (apical, mid-chamber, basal) were used to
calculate ECV with hematocrit values from blood samples.
Patients received 0.2 mmol/kg gadopentetate dimeglumine
or 0.1 mmol/kg gadopentetate dimeglumine contrast at
CMR. Segmental LGE and ECV values were calculated
according to the AHA 16 segment model and compared.
To characterize the presence of LGE in segments with
varying degrees of ECV, patients were separated into LGE
(+) and LGE(-) groups based on the presence of visually
identifiable scar. All segments from LGE(+) patients were
defined as LGE(+) and those from LGE(-) patients as LGE
(-). All segments were pooled and grouped by range of
ECV, and the total number of LGE(+) and LGE(-) seg-
ments for each ECV range was calculated.
Results
45 patients (23 men, mean age 53.4 ± 13.5 years) met cri-
teria, allowing for the evaluation of 720 myocardial seg-
ments. 37.8% of patients (n = 17) had no visually
identifiable scar. Segmental LGE ranged from 0-99.7%
(mean 14.5 ± 17.5%) and segmental ECV ranged from
5.65-64.2% (mean 26.2 ± 6.71%). There was a statistically
significant correlation (p < 0.05) between ECV and LGE in
8 of 16 myocardial regions (Figure 1). LGE was present in
49.9%, 73.2%, and 75.9% of segments with ECV < 25% (n
= 355), 25-30% (n = 224), and > 30% (n = 141) respectively
(Figure 2). ECV > 30% was found in 12.5% of LGE(-)
segments.
Conclusions
The relationship between LGE and ECV in HCM varies by
myocardial region, with mid-septal and antero-septal seg-
ments demonstrating the strongest correlations. Segments
with greater ECV expansion demonstrated a significantly
greater presence of LGE, but significant interstitial fibrosis
can also occur in HCM patients with no visible scar.
Further study is indicated for evaluating the significance
and independent prognostic value of ECV in HCM.
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Figure 1 Correlation between LGE and ECV by myocardial
segment.
Figure 2 Presence of LGE in myocardial segments with varying
levels of ECV.
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